Financial Contrast: Relx (NYSE:RELX) & XBP Global (NASDAQ:XBP)

XBP Global (NASDAQ:XBP) and Relx (NYSE:RELX) are both industrials companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

Analyst Ratings

This is a summary of current ratings and price targets for XBP Global and Relx, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
XBP Global	1	0	1	0	2.00
Relx	0	3	4	1	2.75

XBP Global currently has a consensus target price of $5.00, suggesting a potential upside of 75.44%. Given XBP Global’s higher possible upside, equities analysts plainly believe XBP Global is more favorable than Relx.

Profitability

This table compares XBP Global and Relx’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
XBP Global	134.88%	1,328.38%	122.34%
Relx	N/A	N/A	N/A

Institutional & Insider Ownership

15.7% of XBP Global shares are held by institutional investors. Comparatively, 15.0% of Relx shares are held by institutional investors. 31.4% of XBP Global shares are held by insiders. Comparatively, 0.0% of Relx shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares XBP Global and Relx”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
XBP Global	$791.04 million	0.04	$1.10 billion	($3.70)	-0.77
Relx	$9.72 billion	6.34	$2.72 billion	N/A	N/A

Relx has higher revenue and earnings than XBP Global.

Risk & Volatility

XBP Global has a beta of -0.45, meaning that its stock price is 145% less volatile than the S&P 500. Comparatively, Relx has a beta of 0.72, meaning that its stock price is 28% less volatile than the S&P 500.

Summary

Relx beats XBP Global on 7 of the 13 factors compared between the two stocks.

About XBP Global

XBP Europe Holdings, Inc. provides bills, payments, and related solutions and services in France, Germany, the United Kingdom, Sweden, and internationally. The company operates through two segments, Bills & Payments and Technology. The Bills & Payments segment focuses on optimizing how bills and payments are processed by businesses of all sizes and industries. This segment also offers automation of accounts payable and accounts receivables processes and seeks to integrate buyers and suppliers, as well as engages in digital transformation business. The Technology segment engages in the sale of recurring software licenses and related maintenance, and hardware solutions, as well as provision of related maintenance and professional services. In addition, the company offers XBP platform that provides a secured network allowing billers, consumers, and businesses to communicate and transact; XBP Omnidirect, a cloud-based platform that provides enterprise level client communication management; and Reaktr.ai for cybersecurity, data modernization and cloud management, and generative AI. Further, it provides request to pay solutions; enterprise information management solutions; robotic process automation solutions; digital mailroom and records digitization solutions; business process management and intelligent workflow automation solutions; integrated communications solution; banking and financial industry solutions and services; cross-border payments; digitization of checks; confirmation of payee; and mortgage and loan management solutions. The company is based in Egham, the United Kingdom. XBP Europe Holdings, Inc. operates as a subsidiary of Exela Technologies, Inc.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity. The Risk & Business Analytics segment provides customers with solutions and decision tools that combine public and industry specific content with advanced technology and analytics to assist them in evaluating and predicting risk and enhancing operational efficiency. The Legal segment is a global provider of legal, regulatory and business information and analytics that helps customers increase productivity, improve decision-making and outcomes and advance the rule of law around the world. The Exhibitions segment is an event business, enhancing the effect of face-to-face through data and digital tools. The company was founded by Albert Edward Reed in 1903 and is headquartered in London, the United Kingdom.